tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alex Thompson, 102 are a BUY (88.7%), 13 are a HOLD (11.3%).
Analyst Alex Thompson, currently employed at STIFEL, carries an average stock price target met ratio of 59.69% that have a potential upside of 58.74% achieved within 157 days.
Alex Thompson’s has documented 212 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASND, Ascendis Pharma AS at 31-Aug-2026.
Analyst best performing recommendations are on DICE (DICE MOLECULES HOLDINGS LLC).
The best stock recommendation documented was for ACRS (ACLARIS THERAPEUTICS) at 11/6/2024. The price target of $3 was fulfilled within 12 days with a profit of $0.74 (32.74%) receiving and performance score of 27.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 09-Aug-2023
$48
$0.45 (0.95%)
$48
3 years 30 days ago
(09-Aug-2023)
1/8 (12.5%)
$0.45 (0.95%)
85
Hold Since 26-Jun-2023
$56
3 years 2 months 14 days ago
(26-Jun-2023)
0/1 (0%)
$27.35 (95.46%)
Buy Since 22-May-2023
$48
3 years 2 months 18 days ago
(21-Jun-2023)
0/2 (0%)
$1.56 (3.36%)
Buy Since 14-Sep-2022
$48
$0.45 (0.95%)
$68
3 years 2 months 19 days ago
(20-Jun-2023)
1/3 (33.33%)
$1.56 (3.36%)
27
Hold Since 24-May-2023
$48
$0.45 (0.95%)
$38
3 years 2 months 19 days ago
(20-Jun-2023)
1/2 (50%)
$1.56 (3.36%)
27
Which stock is Alex Thompson most bullish on?
Which stock is Alex Thompson most reserved on?
What Year was the first public recommendation made by Alex Thompson?
